Sight Sciences, Inc. (SGHT)
SGHT moved a median of 0.00% 30 minutes after news, and +0.61% by the close. How SGHT actually reacts to news — the realized, point-in-time move the market made, measured across 417 labeled events over the last three years with zero look-ahead.
SGHT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 412 |
| 30-min | 0.00% | 49% | 415 |
| 60-min | +0.08% | 50% | 415 |
| to close | +0.61% | 56% | 413 |
| Middle 50% of SGHT reactions | -1.27% to +1.46% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 417 |
Half of all Sight Sciences, Inc. news events land between -1.27% and +1.46% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How SGHT reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 11 | +0.29% | 73% | -1.86% |
| Rating reiterations | 66 | +0.10% | 50% | +0.07% |
| Price-target raises | 12 | +0.18% | 58% | +2.49% |
| Price-target cuts | 13 | -0.14% | 39% | +0.14% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how SGHT ranks against every other measured name →
That’s how SGHT usually reacts — get an email when it moves on news →Email me when SGHT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SGHT's baseline. Nothing else.
Recent SGHT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting | Press release | GlobeNewswire | -0.32% | -2.38% | |
| Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15 | Press release | GlobeNewswire | +3.54% | +2.68% | |
| TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease | Press release | GlobeNewswire | +0.12% | +0.35% | |
| Form 8-K Sight Sciences, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | +0.80% | — | |
| Form 10-Q Sight Sciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +14.37% | +22.45% | |
| Form 8-K Sight Sciences, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +14.37% | +22.45% | |
| Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems | Press release | GlobeNewswire | +14.37% | +22.45% | |
| Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System | Press release | GlobeNewswire | -5.98% | -3.81% | |
| Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 | Press release | GlobeNewswire | +0.20% | -5.24% | |
| Form 8-K Sight Sciences, Inc. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.21% | |
| Form SD Sight Sciences, Inc. | SEC filing · Form SD | SEC EDGAR | -2.92% | -5.42% | |
| Form 10-Q Sight Sciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +8.26% | +21.33% | |
| Form 8-K Sight Sciences, Inc. For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +8.26% | +21.33% | |
| Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance | Press release | GlobeNewswire | +8.26% | +21.33% | |
| Sight Sciences to Present at Two Upcoming Investor Conferences | Press release | GlobeNewswire | -0.50% | +3.02% | |
| Form 8-K Sight Sciences, Inc. For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.94% | |
| Form DEF 14A Sight Sciences, Inc. For: Jun 04 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +0.94% | |
| Form DEFA14A Sight Sciences, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +0.94% | |
| Sight Sciences Announces the Release of its Sustainability Report | Press release | GlobeNewswire | +0.00% | +0.94% | |
| Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 | Press release | GlobeNewswire | +0.58% | -0.70% | |
| Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting | Press release | GlobeNewswire | -1.94% | -2.49% | |
| Form 8-K Sight Sciences, Inc. For: Mar 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -5.40% | |
| Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent | Press release | GlobeNewswire | +0.00% | -5.40% | |
| Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th | Press release | GlobeNewswire | -1.59% | -0.27% | |
| Form 10-K Sight Sciences, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -8.65% | -17.50% | |
| Form 8-K Sight Sciences, Inc. For: Mar 04 | SEC filing · Form 8-K | SEC EDGAR | -8.65% | -17.50% | |
| Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance | Press release | GlobeNewswire | -8.65% | -17.50% | |
| Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 | Press release | GlobeNewswire | -0.10% | +4.99% | |
| Form 8-K Sight Sciences, Inc. For: Jan 29 | SEC filing · Form 8-K | SEC EDGAR | +1.00% | -5.85% | |
| Form 8-K Sight Sciences, Inc. For: Jan 13 | SEC filing · Form 8-K | SEC EDGAR | -1.29% | -7.33% | |
| Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights | Press release | GlobeNewswire | -1.29% | -7.33% | |
| New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans | Press release | GlobeNewswire | -0.98% | +6.67% | |
| Form 10-Q Sight Sciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +6.01% | |
| Form 8-K Sight Sciences, Inc. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.01% | |
| Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer | Press release | GlobeNewswire | +0.00% | +6.01% | |
| Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance | Press release | GlobeNewswire | +0.00% | +6.01% | |
| Sight Sciences to Present at Two Upcoming Investor Conferences | Press release | GlobeNewswire | -1.00% | +0.80% | |
| Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | GlobeNewswire | +0.19% | +0.76% | |
| Form 8-K Sight Sciences, Inc. For: Oct 17 | SEC filing · Form 8-K | SEC EDGAR | +2.05% | +20.26% | |
| Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure | Press release | GlobeNewswire | +2.05% | +20.26% | |
| Form 8-K Sight Sciences, Inc. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | -2.33% | -1.76% | |
| Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use | Press release | GlobeNewswire | +0.00% | -2.29% | |
| Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments | Press release | GlobeNewswire | +0.28% | -1.65% | |
| Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO | Press release | GlobeNewswire | -0.26% | -0.78% | |
| Form 8-K Sight Sciences, Inc. For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.49% | |
| Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference | Press release | GlobeNewswire | -1.17% | +0.47% | |
| Form 10-Q Sight Sciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +6.32% | +10.99% | |
| Form 8-K Sight Sciences, Inc. For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +6.32% | +10.99% | |
| Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance | Press release | GlobeNewswire | +6.32% | +10.99% | |
| Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease | Press release | GlobeNewswire | +1.73% | -0.58% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SGHT section they belong to.
Where else SGHT is measured.
SGHT earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Sight Sciences, Inc.'s median reaction calculated?
Every labeled SGHT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 417 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of SGHT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SGHT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.